Sino Biopharmaceutical PE Ratio 2018-2021 | SBMFF
Current and historical p/e ratio for Sino Biopharmaceutical (SBMFF) from 2018 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Sino Biopharmaceutical PE ratio as of October 26, 2021 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
|Sino Biopharmaceutical PE Ratio Historical Data
||TTM Net EPS
||Medical - Biomedical and Genetics
Sino Biopharmaceutical Limited researches, develops, produces and sells biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis. Sino Biopharmaceutical Limited is headquartered in Wanchai, Hong Kong.